Literature DB >> 19278419

CD56bright natural killer (NK) cells: an important NK cell subset.

Aurélie Poli1, Tatiana Michel, Maud Thérésine, Emmanuel Andrès, François Hentges, Jacques Zimmer.   

Abstract

Human natural killer (NK) cells can be subdivided into different populations based on the relative expression of the surface markers CD16 and CD56. The two major subsets are CD56(bright) CD16(dim/) (-) and CD56(dim) CD16(+), respectively. In this review, we will focus on the CD56(bright) NK cell subset. These cells are numerically in the minority in peripheral blood but constitute the majority of NK cells in secondary lymphoid tissues. They are abundant cytokine producers but are only weakly cytotoxic before activation. Recent data suggest that under certain conditions, they have immunoregulatory properties, and that they are probably immediate precursors of CD56(dim) NK cells. CD56(bright) NK cell percentages are expanded or reduced in a certain number of diseases, but the significance of these variations is not yet clear.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278419      PMCID: PMC2673358          DOI: 10.1111/j.1365-2567.2008.03027.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

1.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Authors:  T A Fehniger; M H Shah; M J Turner; J B VanDeusen; S P Whitman; M A Cooper; K Suzuki; M Wechser; F Goodsaid; M A Caligiuri
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients.

Authors:  K Katchar; K Söderström; J Wahlstrom; A Eklund; J Grunewald
Journal:  Eur Respir J       Date:  2005-07       Impact factor: 16.671

5.  Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).

Authors:  K R Solomon; M Chan; R W Finberg
Journal:  Cell Immunol       Date:  1995-10-15       Impact factor: 4.868

6.  Skin infiltration of CD56(bright) CD16(-) natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations.

Authors:  Fumie Shibata; Tomoko Toma; Taizo Wada; Masayuki Inoue; Yumi Tone; Kazuhide Ohta; Yoshihito Kasahara; Fumie Sano; Mitsuaki Kimura; Mitsuru Ikeno; Shoichi Koizumi; Akihiro Yachie
Journal:  Eur J Haematol       Date:  2007-07       Impact factor: 2.997

7.  Perturbations of natural killer cell regulatory functions in respiratory allergic diseases.

Authors:  Francesca Scordamaglia; Mirna Balsamo; Antonio Scordamaglia; Alessandro Moretta; Maria Cristina Mingari; Giorgio Walter Canonica; Lorenzo Moretta; Massimo Vitale
Journal:  J Allergy Clin Immunol       Date:  2007-12-03       Impact factor: 10.793

8.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

9.  The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells.

Authors:  Massimo Vitale; Mariella Della Chiesa; Simona Carlomagno; Chiara Romagnani; Andreas Thiel; Lorenzo Moretta; Alessandro Moretta
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

10.  Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.

Authors:  Massimo Vitale; Jacques Zimmer; Roberta Castriconi; Daniel Hanau; Lionel Donato; Cristina Bottino; Lorenzo Moretta; Henri de la Salle; Alessandro Moretta
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

View more
  295 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 3.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

4.  Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.

Authors:  Helder I Nakaya; Thomas Hagan; Sai S Duraisingham; Eva K Lee; Marcin Kwissa; Nadine Rouphael; Daniela Frasca; Merril Gersten; Aneesh K Mehta; Renaud Gaujoux; Gui-Mei Li; Shakti Gupta; Rafi Ahmed; Mark J Mulligan; Shai Shen-Orr; Bonnie B Blomberg; Shankar Subramaniam; Bali Pulendran
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

5.  Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade.

Authors:  Emanuela Taioli; William K Oh; Yixuan Gong; Li Wang; Haocheng Yu; Naomi Alpert; Mitchell D Cohen; Colette Prophete; Lori Horton; Maureen Sisco; Sung-Hyun Park; Hyun-Wook Lee; Judith Zelikoff; Lung-Chi Chen; Dana Hashim; Mayte Suarez-Farinas; Michael J Donovan; Stuart A Aaronson; Matthew Galsky; Jun Zhu
Journal:  Mol Cancer Res       Date:  2019-06-20       Impact factor: 5.852

6.  Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes.

Authors:  Yang Feng; Yanping Wang; Zhongyu Zhu; Wei Li; Robyn T Sussman; Michael Randall; Kristopher R Bosse; John M Maris; Dimiter S Dimitrov
Journal:  MAbs       Date:  2016-02-24       Impact factor: 5.857

7.  Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells.

Authors:  A Møller-Larsen; T Brudek; T Petersen; E L Petersen; M Aagaard; D T Hansen; T Christensen
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

8.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

9.  Age- and Sex-associated Differences in Phenotypic and Functional Characteristics of Peripheral Blood Lymphocytes in Chimpanzees (Pan troglodytes).

Authors:  Pramod N Nehete; Elizabeth R Magden; Bharti P Nehete; Lawrence E Williams; Christian R Abee; K Jagannadha Sastry
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

Review 10.  Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.